Myasthenia gravis, the Lambert-Eaton myasthenic syndrome, and acquired
neuromyotonia are three disorders of the neuromuscular junction or mo
tor nerve that are caused by autoantibodies to ion channel proteins: a
cetylcholine receptors, voltage-gated calcium channels and voltage-gat
ed potassium channels, respectively. The antibody titres can be measur
ed using the relevant I-125-neurotoxins to label the extracted channel
s. Other disorders of the peripheral motor nerve are associated with a
ntibodies to gangliosides. Sera with raised levels of anti-ganglioside
antibodies have direct effects on the function of the distal motor ne
rve and motor nerve terminal. These conditions can be improved by ther
apies designed to reduce circulating antibodies. Antibodies that bind
to neuronal surface antigens are proving to be of great clinical impor
tance and interest in neurological disorders.